Hansa Biopharma AB (publ) (LON:0RC7)
London · Delayed Price · Currency is GBP · Price in SEK 26.80
-0.46 (-1.69%)
At close: Jul 11, 2025
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 169.33 million as of July 16, 2025. Its market cap has decreased by -25.16% in one year.
Market Cap
169.33M
Enterprise Value
228.38M
Revenue
14.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.80
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 2.62M to 169.33M, an increase of 6,368.29%. That is a compound annual growth rate of 27.37%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 162.05B |
| GSK plc | 56.99B |
| Haleon | 33.01B |
| Smith & Nephew | 9.82B |
| ConvaTec Group | 5.33B |
| Hikma Pharmaceuticals | 4.32B |
| HUTCHMED (China) | 2.02B |
| Genus | 1.46B |